Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...
How throwing stones into water has led to one of Liverpool's most unexpected social groups.
Alexander Zverev, the highest remaining seed in the men's draw, plays Jesper de Jong in the French Open fourth round.
Alexander Zverev, the highest remaining seed in the men's draw, plays Jesper de Jong in the French Open fourth round.
Opinion
LGBTQ Nation on MSNOpinion
“It’s practically a revolution”: Could Trump’s J6 slush fund be the final straw for GOP loyalists?
Republicans are angry, and they're actually fighting back. Will it last?
The npm package has a module field pointing to an ES module variant of the library, mainly to provide support for ES module aware bundlers, whereas its browser field points to an UMD module for full ...
Arsenal had no answer for the relentless passing of PSG and had to retreat deep into their own half as the conditions and ...
Artificial intelligence is helping a London-based singer-songwriter continue writing and recording music after Parkinson’s disease largely took away his ability to play guitar. Samuel Smith relied on ...
Anthropic releases Claude Opus 4.8 with dynamic workflows, 1,000 parallel subagents, and 3x cheaper fast mode. Here's what the new model means for AI developers, enterprises, and the race against ...
Please enable JavaScript to view the comments powered by Disqus.
CHICAGO, May 31, 2026 (GLOBE NEWSWIRE) -- NeuExcell Therapeutics today announced that Dr. Yulun Huang will present the first-in-human clinical study of NXL-004 for recurrent malignant glioma as Rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results